Contribution By Pankaj Singh
Asahi Kasei Corporation has reportedly inked an agreement with Shell Eastern Petroleum Ltd. pertaining to the supply of plastic waste-derived butadiene.
The signing ceremony was conducted during the “Creating the Plastic Circular Economy in Si
Renewable energy company Leeward Renewable Energy LLC has reportedly announced the closure of secured tax equity and construction financing commitments for its Panorama Wind Farm situated in Weld County, Colorado.
MUFG Bank Ltd. acted as a bookrunne
Impossible Foods Inc., a plant-based meat company, has reportedly secured USD 500 million in the latest funding round initiated by current investor Mirae Asset Global Investments, with other existing investors also participating in the round.
SIMM (Shanghai Institute of Materia Medica), CAS (Chinese Academy of Sciences) has reportedly collaborated with Simcere Pharmaceutical Group Limited to develop advanced antiviral COVID-19 drugs.
Under the agreement, Simcere will get the exclusive ri
Nym Technology, a blockchain-powered privacy web company, has reportedly raised USD 13 million in a Series A funding round initiated by venture capitalist Andreessen Horowitz (a16z Crypto).
Digital Currency Group, the parent company of Grayscale, Fe
Exxon Mobil Corp has reportedly offered to lease around half-million acres off the coast of Texas for an upcoming project for capturing and storing carbon emissions.
The company has been pressurized by investors to acknowledge climate change. In Apr
Apple Inc. has reportedly announced the Self Service Repair program, which is designed to enable users to perform general repairs on their devices at home. The program will be launched in early 2022 in the United States and the store will provide clo
Afresh Technologies, an AI-driven tech company transforming the supply chain of fresh food, has reportedly partnered with The Save Mart Companies, the largest family owned grocer in California. The Save Mart Companies will introduce the Fresh Operati
Kezar Life Sciences Inc., a clinical-stage biotech company, has reportedly released interim results from Phase 2 of its clinical trial MISSION that evaluates KZR-616, a selective immunoproteasome inhibitor, in patients with proliferative, active lupu